Korro Bio, Inc. (KRRO) vs Spruce Biosciences, Inc. (SPRB)

Korro Bio, Inc. and Spruce Biosciences, Inc. are both Biotechnology companies. Korro Bio, Inc. and Spruce Biosciences, Inc. are of similar size ($140.9M and $140.9M). Spruce Biosciences, Inc. grew revenue faster over the last twelve months: −51.3% against −81.9%. Across the 12 metrics below, Spruce Biosciences, Inc. leads on 7 and Korro Bio, Inc. on 5.

Valuation

Metric KRRO SPRB Biotechnology median
P/E n/m n/m 7.88
P/S 26.38 24.12 11.47
P/B 1.63 1.41 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 12.73 5.95 10.73
Earnings yield (104.49%) (81.65%) (28.84%)
Free cash flow yield (40.49%) (36.12%) (23.03%)

Profitability

Metric KRRO SPRB Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (97.69%) (105.98%) (57.72%)
Return on assets (62.03%) (82.38%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KRRO SPRB Biotechnology median
Revenue growth (TTM) (81.87%) (51.32%) 5.64%
EPS growth (last fiscal year) (33.19%) 47.59% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KRRO SPRB Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 9.55 9.23 4.73
Net debt to EBITDA 0.64 1.34 0.96

Dividend

Metric KRRO SPRB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric KRRO SPRB Biotechnology median
Market cap 140.92m 140.88m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack